ALGS - Aligos Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

ALGS is currently covered by 3 analysts with an average price target of $30. This is a potential upside of $28.78 (2359.02%) from yesterday's end of day stock price of $1.22.

Aligos Therapeutics's activity chart (see below) currently has 32 price targets and 40 ratings on display. The stock rating distribution of ALGS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 20.11% of the time, taking 44.33 days on average.

Highest price target for ALGS is $50, Lowest price target is $20, average price target is $30.

Most recent stock forecast was given by STEVEN SEEDHOUSE from CANTOR FITZGERALD on 29-May-2026. First documented stock forecast 09-Nov-2020.

Currently out of the existing stock ratings of ALGS, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-May-2026

$20

$18.78 (1539.34%)

$20

5 months 23 days ago
(29-May-2026)

0/2 (0%)

$14.3 (250.88%)

Buy Since 22-Jan-2026

$50

$48.78 (3998.36%)

7 months 4 days ago
(17-Apr-2026)

0/3 (0%)

$43.32 (648.50%)

Buy Since 06-Jan-2026

$20

$18.78 (1539.34%)

$75

10 months 14 days ago
(06-Jan-2026)

2/5 (40%)

$10.35 (107.25%)

22

Buy Since 12-Mar-2025

$50

1 years 3 months 3 days ago
(18-Aug-2025)

0/2 (0%)

$41.23 (470.13%)

Buy Since 17-May-2024

$7

2 years 1 months 28 days ago
(24-Sep-2024)

3/5 (60%)

$-5.6 (-44.44%)

119

Show more analysts

Please expand the browser size to see the chart

What is ALGS (Aligos Therapeutics) average time for price targets to be met?

On average it took 44 days for the stock forecasts to be reached, with an average price target met ratio of 20.11%.

Which analyst most recently updated their price target on ALGS (Aligos Therapeutics)?

Steven Seedhouse

Which analyst has the lowest performance score on ALGS (Aligos Therapeutics) with a proven track record?

STEVEN SEEDHOUSE

Which analyst has the most public recommendations on ALGS (Aligos Therapeutics)?

Steven Seedhouse works at CANTOR FITZGERALD and has 8 price targets and 5 ratings on ALGS

Which analyst is the currently most bullish on ALGS (Aligos Therapeutics)?

Tyler Van Buren with the highest potential upside of $1173.78

Which analyst is the currently most reserved on ALGS (Aligos Therapeutics)?

Yasmeen Rahimi with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?